drugset / Trial / NCT00497471
RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian Infants
Terminated
832 enrolled
Hospital Clinic of Barcelona
Agencia Española de Cooperación Internacional · collabWorld Health Organization · collab
RandomizedFactorialDouble-blindPrevention
Summary
The purpose of this trial is to evaluate the efficacy of weekly iron supplementation and the efficacy of malaria chemoprophylaxis from 2 to 12 months of age in infants living in an area of intense and perennial malaria transmission
Timeline
- Start
- 1995-02
- Primary completion
- —
- Completion
- 1999-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapsone | Small molecule | 25 mg | — |
| Subject | Iron Sulfate | Small molecule | 2 mg/kg | Oral |
| Subject | pyrimethamine | Small molecule | 3.125 mg | — |